Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
about
Dipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular DiseaseRecent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical TrialsPleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemBeneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.Suppression of pancreatic beta cell apoptosis by Danzhi Jiangtang capsule contributes to the attenuation of type 1 diabetes in ratsEffect of the low- versus high-intensity exercise training on endoplasmic reticulum stress and GLP-1 in adolescents with type 2 diabetes mellitusLower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome.Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients.DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposityCirculating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.Altered blood flow in cerebral perforating arteries of rat models of diabetes: A synchrotron radiation microangiographic study toward clinical evaluation of white matter hyperintensities.Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
P2860
Q26781269-819C13A2-5BBF-4FAE-A700-F2F8025840EAQ28081569-5AF6E0AF-2E8E-4D60-BC15-E894137BC497Q34062829-79CC0714-658F-433C-94A3-EE3546A1916EQ35860311-2F97B7FF-0528-46D2-B853-C1B21229DF6CQ35906592-1F94B6D1-B990-4E91-BD47-C0A1CDDD4393Q36342594-121EC3FB-2A54-4C4E-B31B-0E810FEAF0ECQ37301797-6B3653B8-1631-4DB7-97DE-69CA777FC1EFQ37522403-D7B67031-B839-4394-9B5D-A0BBFB4E4D79Q41153628-AD15DF02-6765-40CA-82CA-4F6F822AD90EQ41686499-A94189F6-99A7-4BB1-853D-71824283BD8DQ48229830-0C65E562-7AE6-4721-A7D4-F31AC434326AQ49144700-C363D552-0F5C-45BC-8017-473CAA7D47C4Q53696333-CA473E1B-F715-48D8-BC47-F68FB5D78D9BQ54242863-B62C69BD-D96B-4B9B-888F-234643F2D69B
P2860
Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@en
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@nl
type
label
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@en
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@nl
prefLabel
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@en
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@nl
P2093
P2860
P1476
Altered dipeptidyl peptidase-4 ...... te-stage type 2 diabetic rats.
@en
P2093
Kazuo Minakuchi
Kazuyoshi Kawazoe
Takayuki Kamimoto
Yasushi Kirino
Youichi Sato
P2860
P304
P356
10.1152/AJPENDO.00319.2010
P577
2010-12-07T00:00:00Z